Cumberland Pharmaceuticals (CPIX) Reports Q4 Loss of $0.05

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of ($0.05), versus $0.01 reported last year. Revenue for the quarter came in at $9 million, versus $7.89 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Forgent Power Solutions, Inc. (FPS) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY27 Guidance
• Vera Bradley (VRA) Tops Q2 EPS by 10c ; Offers Guidance